Hyperfine Enrolls First Patients in Portable MRI Evaluation Study

, MT Newswires -  4:40 PM ET 4/15/2025 Company News

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

04:40 PM EDT, 04/15/2025 (MT Newswires) -- Hyperfine (HYPR) said late Tuesday that it enrolled initial patients in a study that will assess the use of portable ultra-low-field magnetic resonance imaging, or MRI, in neurology offices.

The study will compare portable low-field MRI and conventional high-field MRI for pathology findings, clinical utility and patient experience, the company said.

Hyperfine said it plans to enroll 100 patients in the study and complete the trial by year-end.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.